Role of tumor-associated macrophages in tumor progression and invasion (original) (raw)

References

1. Balkwill, F., & Mantovani, A. (2001). Inflammation and cancer: Back to Virchow? Lancet, 357, 539–545.
   Article CAS PubMed Google Scholar
2. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., & Sica, A. (2002). Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology, 23, 549–555.
   Article CAS PubMed Google Scholar
3. Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., et al. (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New England Journal of Medicine, 351, 2817–2826.
   Article CAS PubMed Google Scholar
4. Koehne, C. H. (2004). Dubois RN: COX-2 inhibition and colorectal cancer. Seminars in Oncology, 31, 12–21.
   Article CAS PubMed Google Scholar
5. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., et al. (2003). IL-1 is required for tumor invasiveness and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 100, 2645–2650.
   Article CAS PubMed Google Scholar
6. Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., et al. (2004). A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors Cancer Research, 64, 7022–7029.
   Article CAS PubMed Google Scholar
7. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., et al. (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461–466.
   Article CAS PubMed Google Scholar
8. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285–296.
   Article CAS PubMed Google Scholar
9. Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860–867.
   Article CAS PubMed Google Scholar
10. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., & Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology, 25, 677–686.
    Article CAS PubMed Google Scholar
11. Sher, A., Pearce, E., & Kaye, P. (2003). Shaping the immune response to parasites: Role of dendritic cells. Current Opinion in Immunology, 15, 421–429.
    Article CAS PubMed Google Scholar
12. Balkwill, F., Charles, K. A., & Mantovani, A. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 7, 211–217.
    Article CAS PubMed Google Scholar
13. Gordon, S. (2003). Alternative activation of macrophages. Natural Reviews. Immunology, 3, 23–35.
    Article CAS Google Scholar
14. Mosser, D. M. (2003). The many faces of macrophage activation. Journal of Leukocyte Biology, 73, 209–212.
    Article CAS PubMed Google Scholar
15. Goerdt, S., & Orfanos, C. E. (1999). Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity, 10, 137–142.
    Article CAS PubMed Google Scholar
16. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992). The origin and function of tumor-associated macrophages. Immunology Today, 13, 265–270.
    Article CAS PubMed Google Scholar
17. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100, 57–70.
    Article CAS PubMed Google Scholar
18. Karin, M., Cao, Y., Greten, F. R., & Li, Z. W. (2002). NF-kappaB in cancer: From innocent bystander to major culprit. Nature Reviews. Cancer, 2, 301–310.
    Article CAS PubMed Google Scholar
19. Mantovani, A. (2005). Cancer: Inflammation by remote control. Nature, 435, 752–753.
    Article CAS PubMed Google Scholar
20. Luo, J. L., Maeda, S., Hsu, L. C., Yagita, H., & Karin, M. (2004). Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell, 3, 297–305.
    Article Google Scholar
21. Andela, V. B., Schwarz, E. M., Puzas, J. E., O'Keefe, R. J., & Rosier, R. N. (2000). Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Research, 60, 6557–6562.
    CAS PubMed Google Scholar
22. Pahl, H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853–6866.
    Article CAS PubMed Google Scholar
23. Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., & Fidler, I. J. (2001). Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20, 4188–4197.
    Article CAS PubMed Google Scholar
24. Baldwin, A. S. Jr. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annual Review of Immunology, 14, 649–683.
    Article CAS PubMed Google Scholar
25. Ghosh, S., May, M. J., & Kopp, E. B. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annual Review of Immunology, 16, 225–260.
    Article CAS PubMed Google Scholar
26. Baldwin, A. S. (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. Journal of Clinical Investigation, 107, 241–246.
    Article CAS PubMed Google Scholar
27. Wolf, J. S., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., et al. (2001). IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.Clinical Cancer Research, 7, 1812–1820.
    CAS PubMed Google Scholar
28. Orlowski, R. Z., & Baldwin, A. S., Jr. (2002). NF-kappaB as a therapeutic target in cancer. Trends in Molecular Medicine, 8, 385–389.
    Article CAS PubMed Google Scholar
29. Karin, M., Yamamoto, Y., & Wang, Q. M. (2004). The IKK NF-kappa B system: A treasure trove for drug development. Nat Rev Drug Discov, 3, 17–26.
    Article CAS PubMed Google Scholar
30. Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., van Damme, J., et al. (2000). Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. Journal of Immunology, 164, 762–767.
    CAS Google Scholar
31. Dinapoli, M. R., Calderon, C. L., & Lopez, D. M. (1996). The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. Journal of Experimental Medicine, 183, 1323–1329.
    Article CAS PubMed Google Scholar
32. Ghosh, P., Komschlies, K. L., Cippitelli, M., Longo, D. L., Subleski, J., Ye, J., et al. (1995). Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. Journal of the National Cancer Institute, 87, 1478–1483.
    CAS PubMed Google Scholar
33. Vaupel, P. (2004). The role of hypoxia-induced factors in tumor progression. Oncologist, 9, 10–17.
    Article CAS PubMed Google Scholar
34. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Natural Reviews. Cancer, 3, 721–732.
    Article CAS Google Scholar
35. Schlappack, O. K., Zimmermann, A., & Hill, R. P. (1991). Glucose starvation and acidosis: Effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. British Journal of Cancer, 64, 663–670.
    CAS PubMed Google Scholar
36. Snyder, S. A., Lanzen, J. L., Braun, R. D., Rosner, G., Secomb, T. W., Biaglow, J., et al. (2001). Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. International Journal of Radiation Oncology, Biology, Physics, 51, 494–506.
    Article CAS PubMed Google Scholar
37. Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfor, K., Rofstad, E. K., et al. (2000). High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Research, 60, 916–921.
    CAS PubMed Google Scholar
38. Sen, S., Zhou, H., Zhang, R. D., Yoon, D. S., Vakar-Lopez, F., Ito, S., et al. (2002). Amplification/overexpression of a mitotic kinase gene in human bladder cancer. Journal of the National Cancer Institute, 94, 1320–1329.
    CAS PubMed Google Scholar
39. Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Koch, C., et al. (2000). Candidate genes for the hypoxic tumor phenotype. Cancer Research, 60, 883–887.
    CAS PubMed Google Scholar
40. Czekay, R. P., Aertgeerts, K., Curriden, S. A., & Loskutoff, D. J. (2003). Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. Journal of Cell Biology, 160, 781–791.
    Article CAS PubMed Google Scholar
41. Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., et al. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. American Journal of Pathology, 157, 411–421.
    CAS PubMed Google Scholar
42. Knowles, H., Leek, R., & Harris, A. L. (2004). Macrophage infiltration and angiogenesis in human malignancy. Novartis Foundation Symposium, 256, 189–200.
    CAS PubMed Google Scholar
43. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., et al. (2003). HIF-1α is essential for myeloid cell-mediated inflammation. Cell, 112, 645–657.
    Article CAS PubMed Google Scholar
44. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., et al. (2003). Regulation of the chemokine receptor CXCR4 by hypoxia. Journal of Experimental Medicine, 198, 1391–1402.
    Article CAS PubMed Google Scholar
45. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Natural Medicine, 10, 858–864.
    Article CAS Google Scholar
46. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50–56.
    Article CAS PubMed Google Scholar
47. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003). Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell, 3, 347–361.
    Article PubMed Google Scholar
48. Giaccia, A., Siim, B. G., & Johnson, R. S. (2003). HIF-1 as a target for drug development. Nat Rev Drug Discov, 2, 803–811.
    Article CAS PubMed Google Scholar
49. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Natural Medicines, 1, 27–31.
    Article CAS Google Scholar
50. Hanahan, D., & Folkman, J. (1996). Patterns of emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353–364.
    Article CAS PubMed Google Scholar
51. Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001). Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. Journal of Leukocyte Biology, 70, 478–490.
    CAS PubMed Google Scholar
52. Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M., Anver, M. R., et al. (1999). Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. American Journal of Pathology, 154, 1125–1135.
    CAS PubMed Google Scholar
53. Cursiefen, C., Chen, L., Borges, L. P., Jackson, D., Cao, J., Radziejewski, C., et al. (2004). VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. Journal of Clinical Investigation, 113, 1040–1050.
    Article CAS PubMed Google Scholar
54. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., et al. (2002). Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. American Journal of Pathology, 161, 947–956.
    CAS PubMed Google Scholar
55. Hotchkiss, K. A., Ashton, A. W., Klein, R. S., Lenzi, M. L., Zhu, G. H., & Schwartz, E. L. (2003). Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Research, 63, 527–533.
    CAS PubMed Google Scholar
56. Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., et al. (2002). The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity. Cancer Research, 62, 1093–1102.
    CAS PubMed Google Scholar
57. Haghnegahdar, H., Du, J., Wang, D., Strieter, R. M., Burdick, M. D., Nanney, L. B., et al. (2000). The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. Journal of Leukocyte Biology, 67, 53–62.
    CAS PubMed Google Scholar
58. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., et al. (2000). Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clinical Cancer Research, 6, 3282–3289.
    CAS PubMed Google Scholar
59. Bonizzi, G., & Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends in Immunology, 25, 280–288.
    Article CAS PubMed Google Scholar
60. Li, Q., & Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nature reviews. Immunology, 2, 725–734.
    Article CAS PubMed Google Scholar
61. Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., et al. (1999). Tumour necrosis factor-a deficient mice are resistant to skin carcinogenesis. Natural Medicines, 5, 828–831.
    Article CAS Google Scholar
62. Hagemann, T., Robinson, S. C., Schulz, M., Trumper, L., Balkwill, F. R., & Binder, C. (2004). Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis, 25, 1543–1549.
    Article CAS PubMed Google Scholar
63. Pollard, Jeffrey W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews Cancer, 4, 71–78.
    Article CAS PubMed Google Scholar
64. Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. Journal of Experimental Medicine, 193, 727–740.
    Article CAS PubMed Google Scholar
65. Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., et al. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell, 2, 289–300.
    Article CAS PubMed Google Scholar
66. Grimshaw, M. J., Wilson, J. L., & Balkwill, F. R. (2002). Endothelin-2 is a macrophage chemoattractant: Implications for macrophage distribution in tumors. Europrean Journal of Immunology, 32, 2393–2400.
    Article CAS Google Scholar
67. Grimshaw, M. J. (2005). Endothelins in breast tumour cell invasion. Cancer Letter, 222, 129–138.
    Article CAS Google Scholar
68. Browatzki, M., Pfeiffer, C. A., Schmidt, J., & Kranzhofer, R. (2005). Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB. European Journal of Medical Research, 10, 197–201.
    CAS PubMed Google Scholar
69. Spinella, F., Rosano, L., Di Castro, V., Natali, P. G., & Bagnato, A. (2002). Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. Journal of Biological Chemistry, 277, 27850–27855.
    Article CAS PubMed Google Scholar
70. Leek, R. D., & Harris, A. L. (2002). Tumor-associated macrophages in breast cancer. Journal of Mammary Gland Biology and Neoplasia, 7, 177–189.
    Article PubMed Google Scholar
71. O'Sullivan, C., & Lewis, C. E. (1994). Tumour-associated leucocytes: Friends or foes in breast carcinoma. Journal of Pathology, 172, 229–235.
    Article PubMed Google Scholar
72. Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., & Pollard, J. W. (2002). The macrophage growth factor CSF-1 in mammary gland development and tumor progression. Journal of Mammary Gland Biology and Neoplasia, 7, 147–162.
    Article PubMed Google Scholar
73. Ishikawa, S., Egami, H., Kurizaki, T., Akagi, J., Tamori, Y., Yoshida, N., et al. (2003). Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. Journal of Experimental and Clinical Cancer Research, 22, 299–306.
    CAS Google Scholar
74. Eubank, T. D., Galloway, M., Montague, C. M., Waldman, W. J., Marsh, C. B. (2003). M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. Journal of Immunology, 171, 2637–2643.
    CAS Google Scholar
75. Hildenbrand, R., Dilger, I., Horlin, A., & Stutte, H. J. (1995). Urokinase and macrophages in tumour angiogenesis. British Journal of Cancer, 72, 818–823.
    CAS PubMed Google Scholar
76. Klimetzek, V., & Sorg, C. (1977). Lymphokine-induced secretion of plasminogen activator by murine macrophages. European Journal of Immunology, 7, 185–187.
    CAS PubMed Google Scholar
77. Ahmed, F., Wyckoff, J., Lin, E. Y., Wang, W., Wang, Y., Hennighausen L., et al. (2002). GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Research, 62, 7166–7169.
    CAS PubMed Google Scholar
78. Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., et al. (2005). Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Research, 65, 5278–5283.
    Article CAS PubMed Google Scholar
79. Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 103, 481–490.
    Article CAS PubMed Google Scholar
80. Locati, M., Deuschle, U., Massardi, M. L., Martinez, F. O., Sironi, M., Sozzani, S., et al. (2002). Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. Journal of Immunology, 168, 3557–3562.
    CAS Google Scholar
81. Bronte, V., & Zanovello, P. (2005). Regulation of immune responses by l-arginine metabolism. Nature Reviews. Immunology, 5, 641–654.
    Article CAS PubMed Google Scholar
82. de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005). De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell, 7, 411–423.
    Article PubMed CAS Google Scholar
83. Grohmann, U., Fallarino, F., & Puccetti, P. (2003). Tolerance, DCs and tryptophan: Much ado about IDO. Trends in Immunology, 24, 242–248.
    Article CAS PubMed Google Scholar
84. Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005). Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Natural Medicines, 11, 312–319.
    Article CAS Google Scholar

Download references